0
Abstract: Slide Presentations |

Comparison of nebulized ipratropium bromide with salbutamol versus salbutamol alone in acute asthma exacerbation in children FREE TO VIEW

Apassorn Watanasomsiri, MD*; Wanda Phipatanakul, MD
Author and Funding Information

Thammasat Hospital, Thammasat University, Prathumthani, Thailand


Chest


Chest. 2004;126(4_MeetingAbstracts):761S. doi:10.1378/chest.126.4_MeetingAbstracts.761S-b
Text Size: A A A
Published online

Abstract

PURPOSE:  To determine the effect of adding ipratropium bromide(IB) to salbutamol compared with salbutamol alone for acute asthma exacerbation in children.

METHODS:  In a double-blind, randomized, control trial, 74 children aged 3 to 15 years were enrolled in the study. Subjects were randomized to receive 3 doses of nebulized salbutamol mixed with normal saline or IB every 20 min then additional doses of salbutamol were given every 30 min as needed. Outcome measures were assessed at 40, 70, 100, and 120 min. Primary outcomes were the differences in % change in clinical score (PCC) and % change in peak expiratory flow rate (PPEFR). Secondary outcomes included change in % predicted peak expiratory flow rate (PDPEFR) and additional salbutamol required.

RESULTS:  Thirty three subjects received salbutamol alone (control group) and 38 subjects received the combined IB and salbutamol (treatment group). PPEFR and PDPEFR at any time line of the treatment group were higher without statistically significant difference (NS). Number of subjects with 100% PPEFR at any time point was greater and number of subjects received additional salbutamol at 100 min was lower in the treatment group (NS). There were no significant difference in PCC in the whole group and in the stratified subgroup analysis by age and severity.

CONCLUSION:  Although this study did not demonstrate a significant advantage in clinical score and PEFR, the trend toward additional effect of IB was consistent with previous study.

CLINICAL IMPLICATIONS:  Additional use of IB is considered in acute asthma exacerbation in children.

DISCLOSURE:  A. Watanasomsiri, None.

Tuesday, October 26, 2004

2:30 PM- 4:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
Guidelines
Treatment of acute exacerbation of asthma.
Finnish Medical Society Duodecim | 1/25/2008
Long-term management of asthma.
Finnish Medical Society Duodecim | 1/11/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543